Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Hematological alterations and thymic function in newborns of HIV-infected mothers receiving antiretroviral drugs.

Wongnoi R, Penvieng N, Singboottra P, Kingkeow D, Oberdorfer P, Sirivatanapa P, Pornprasert S.

Indian Pediatr. 2013 Jun 8;50(6):567-72. Epub 2012 Dec 5.

3.

[Correction of anaemia in HIV-positive pregnant women receiving antiretroviral therapy].

Krugova LV, Vartanov VIa, Khutorskaia NN, Lapteva IV, Shifman EM.

Anesteziol Reanimatol. 2012 Nov-Dec;(6):17-21. Russian.

PMID:
23662513
4.

A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.

Alimenti A, Forbes JC, Oberlander TF, Money DM, Grunau RE, Papsdorf MP, Maan E, Cole LJ, Burdge DR.

Pediatrics. 2006 Oct;118(4):e1139-45. Epub 2006 Aug 28.

PMID:
16940166
5.

Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?

Kourtis AP.

J Infect Dis. 2010 Apr 1;201(7):978-80. doi: 10.1086/651233. No abstract available.

6.

Antiretroviral pharmacology: special issues regarding pregnant women and neonates.

Mirochnick M, Best BM, Clarke DF.

Clin Perinatol. 2010 Dec;37(4):907-27, xi. doi: 10.1016/j.clp.2010.08.006. Review.

PMID:
21078458
7.

[In-utero antiretroviral exposure and mitochondrial toxicity in a cohort of uninfected infants born to HIV-1-infected women].

Fernández Ibieta M, Cano JM, Amador JT, González-Tomé MI, Martín SG, Gómez MN, de José MI, Beceiro J, Iglesias E, Prieto L, Santos MJ, Guardia NM, Roa MA, Regidor J.

An Pediatr (Barc). 2010 Oct;73(4):180-8. doi: 10.1016/j.anpedi.2010.02.004. Spanish.

8.

[Anaesthesia and intensive care characteristics in HIV-infected pregnant patients receiving the antiretroviral therapy].

Krugova LV, Vartanov VIa, Vartanova IV, Shakhovskaia IN, Khutorskaia NN, Lapteva IV.

Anesteziol Reanimatol. 2010 Nov-Dec;(6):32-6. Russian.

PMID:
21400795
9.

[Haemostasis disorders and ways of its correction in HIV-positive pregnant women receiving chemopreventive antiretroviral therapy].

Vartanov VIa, Krugova LV, Shifman EM.

Anesteziol Reanimatol. 2012 Nov-Dec;(6):13-7. Russian.

PMID:
23662512
10.

Considerations on the potential teratogenic effects of antiretroviral therapy.

Meli M, Vicidomini S, Bartoloni A.

Intern Emerg Med. 2006;1(3):249-50. No abstract available.

PMID:
17120478
11.

Antiviral and antiretroviral use in pregnancy.

Money DM.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):731-49, vii. Review.

PMID:
14719848
12.

Antiretroviral use during pregnancy for treatment or prophylaxis.

Sturt AS, Read JS.

Expert Opin Pharmacother. 2011 Aug;12(12):1875-85. doi: 10.1517/14656566.2011.584062. Epub 2011 May 3. Review.

PMID:
21534886
13.

The safety of antiretroviral drugs in pregnancy.

Thorne C, Newell ML.

Expert Opin Drug Saf. 2005 Mar;4(2):323-35. Review.

PMID:
15794723
14.

[Pregnancy and human immunodeficiency virus].

Ceccaldi PF, Gavard L, Mandelbrot L.

J Gynecol Obstet Biol Reprod (Paris). 2008 Mar;37 Suppl 1:34-40. Review. French. No abstract available.

15.

Laboratory abnormalities among HIV-1-infected pregnant women receiving antiretrovirals in Latin America and the Caribbean.

Ceriotto M, Harris DR, Duarte G, Gonin R, Aguiar RP, Warley EM, Madi JM, Zala CA, Read JS; NICHD International Site Development Initiative (NISDI) Perinatal Study Group.

AIDS Patient Care STDS. 2008 Mar;22(3):167-71. doi: 10.1089/apc.2007.0080. No abstract available.

PMID:
18338942
16.

Safety and tolerability of antiretrovirals during pregnancy.

Weinberg A, Forster-Harwood J, Davies J, McFarland EJ, Pappas J, Kinzie K, Barr E, Paul S, Salbenblatt C, Soda E, Vazquez A, Levin MJ.

Infect Dis Obstet Gynecol. 2011;2011:867674. doi: 10.1155/2011/867674. Epub 2011 Apr 11.

17.

Leukocyte telomere length in HIV-infected pregnant women treated with antiretroviral drugs during pregnancy and their uninfected infants.

Imam T, Jitratkosol MH, Soudeyns H, Sattha B, Gadawski I, Maan E, Forbes JC, Alimenti A, Lapointe N, Lamarre V, Money DM, Côté HC; CIHR Emerging Team Grant on HIV Therapy and Aging: CARMA.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):495-502.

PMID:
22580562
18.

Mitochondrial disease in the offspring as a result of antiretroviral therapy.

Venhoff N, Walker UA.

Expert Opin Drug Saf. 2006 May;5(3):373-81. Review.

PMID:
16610967
19.

Antiretroviral therapy and pregnancy: effect on cortical bone status of human immunodeficiency virus-infected Caucasian women as assessed by quantitative ultrasonography.

Mora S, Diceglie C, Viganò A, Giacomet V, Manfredini V, Stucchi S, Fabiano V, Mameli C, Coletto S, Zuccotti GV.

Calcif Tissue Int. 2013 Apr;92(4):394-8. doi: 10.1007/s00223-013-9696-8. Epub 2013 Jan 11.

PMID:
23307187
20.

Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue?

Soler-Palacín P, Martín-Nalda A, Martínez-Gómez X, Melendo S, Riudor E, Arranz JA, Espiau M, Figueras C.

AIDS Res Hum Retroviruses. 2012 Aug;28(8):752-8. doi: 10.1089/AID.2011.0198. Epub 2011 Nov 16.

PMID:
22010980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk